Why Metabolites

Metabolites are small molecules like glucose & cholesterol that are produced during metabolic processes.

They direct readouts of both genetic & non-genetic factors associated with disease and drug response.

Metabolites are secreted to the blood from normal tissues and disease cells.

The study of <200 blood metabolites in >117,000 individuals predicted multi-disease outcomes. (Nature Medicine, 28, 2022, 2309–2320)

Our patented technology can characterize 20x more metabolites than any other platform for each patient.

We then combine metabolomic data with multi-modal datasets to discover the right treatments for the right patients.

Learn more

How does our technology work?

Precision Cardio-metabolic

Data-driven approach to treat patients suffering from cardio-metabolic diseases

Cardiometabolic treatments are currently determined based on limited factors such as BMI, blood glucose, and basic lipid panels.

We analyze 10,000+ lipids and metabolites to precisely predict which patients develop which complications.

Our digital disease models further predict the right treatment for each patient.

Partner with us

We believe in the power of partnerships to bring the right treatment for the right patients faster

Pipeline expansion

By utilizing multi-modal metabolomics data, we identify novel biological insights to discover new targets, prioritize them in development, explore indication expansion, and strategize drug combinations.

Optimized clinical trial design

We enhance clinical trial design by developing fine-tuned AI models based on proprietary pre-trained foundation models. These models identify patients most likely to respond and facilitate data-driven covariate identification and adjustment.

Integration with ctDNA tests

Our metabolomics data and pre-trained foundation models improve patient genetic stratification. We partner with liquid biopsy companies to increase the accuracy of their ctDNA tests by integrating metabolomics data.

Contact us

Learn more: